Tradestie Institutional Equity Comparison Engine

RAPT vs ORKA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ORKA Overall Edge

ORKA Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Oruka Therapeutics, Inc. Common Stock (ORKA) driven by superior Growth & Margin, Options & Structure while RAPT counters with relative strength in Momentum & Technical. Fundamentally, RAPT trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus ORKA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, RAPT sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against ORKA sits in BREAKOUT (19th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RAPT N/M vs ORKA N/M Fwd P/E
Growth & Margin Winner ORKA
Op Margin 0.0% vs 0.0% ยท YoY -100.0% vs +0.0%
Momentum & Technical Winner RAPT
1Y +480.2% vs +278.4% ยท 52W Pos 100% vs 83%
Options & Structure Winner ORKA
UNCLASSIFIED (<1st %ile IV) vs BREAKOUT (19th %ile IV)
RAPT NASDAQ
RAPT Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$58.02
+0.07% 1D
Market Cap $1.7B
1M Return +0.68%
1Y Return +480.2%
Forward P/E N/M
Unified AI Score
52.4 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 61.0 Mom 40.0
ORKA NASDAQ
Oruka Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$99.83
-5.23% 1D
Market Cap $7.1B
1M Return +38.79%
1Y Return +278.45%
Forward P/E N/M
Unified AI Score
43.3 / 100 HOLD
Tech 24.0 Fund 40.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RAPT +480.2% ORKA +278.45% Spread: +77.54 pp (RAPT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RAPT TTM Op. Margin: 0.0% ORKA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RAPT vs ORKA. Trailing 12-month operating profitability (RAPT 0.0% vs ORKA 0.0%) and valuation multiples (RAPT N/M vs ORKA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RAPT (3) vs ORKA (3)
Institutional Metric RAPT ORKA Criterion Row Winner
Market Capitalization Scale $1.7B $7.1B Larger Scale ORKA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% +0.0% Higher Growth ORKA
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -85.4% -18.1% Higher ROE ORKA
52-Week Range Position Momentum 100% ($1โ€“$58) 83% ($25โ€“$116) Stronger Trend RAPT
Beta / 30D Volatility Risk Regime -0.02ฮฒ ยท 2% Vol 1.35ฮฒ ยท 68% Vol Lower Realized Risk RAPT
Unified Institutional Score Composite Signal 52.4 / 100 (HOLD) 43.3 / 100 (HOLD) Higher Composite RAPT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RAPT vs ORKA Buy Guide
RAPT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live RAPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ORKA BREAKOUT
141d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 19th %ile
IV Regime Compressed (<25th %ile)
Live ORKA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RAPT nor ORKA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.